High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP
I. de Souza, L. K. S. Monteiro, C. B. Guedes, M. M. Silva, M. Andrade-Tomaz, B. Contieri, M. T. Latancia, D. Mendes, B. F. M. M. Porchia,...
top of page
Nossos Trabalhos
Aqui você encontra os principais resultados de nossos trabalhos, expostos através de publicações variadas em distintas revistas.
- 21 de jun. de 2022
Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment
Izadora de Souza, Maria Carolina Clares Ramalho, Camila Banca Guedes, Isabeli Yumi Araújo Osawa, Linda Karolynne Seregni Monteiro,...
- 1 de dez. de 2020
Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries
Clarissa Ribeiro Reily Rocha, Alexandre Reily Rocha, Matheus Molina Silva, Luciana Rodrigues Gomes, Marcela Latância, Marina Andrade Tomaz,
- 20 de abr. de 2018
DNA repair pathways and cisplatin resistance: an intimate relationship
Clarissa Ribeiro Reily Rocha, Matheus Molina Silva, Annabel Quinet, Januario Bispo Cabral-Neto, Carlos Frederico Martins Menck, Clinics, 201
- 17 de jun. de 2016
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
Clarissa Ribeiro Reily Rocha, Gustavo Satoru Kajitani, Annabel Quinet, Rodrigo Soares Fortunato, and Carlos Frederico Martins Menck,...
- 30 de out. de 2014
Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in
CRR Rocha , CCM Garcia, DB Vieira , A Quinet , LC de Andrade-Lima , V Munford , JE Belizário and CFM Menck
- 23 de set. de 2012
The role of DNA repair in the pluripotency and differentiation of human stem cells
Clarissa Ribeiro Reily Rocha, Leticia Koch Lerner, Oswaldo Keith Okamoto, Maria Carolina Marchetto, Carlos Frederico Martins Menck
bottom of page